VYGR (VYGR) Stock Price & Analysis
VYGR (VYGR) rose 3.85% to USD 3.51 as of September 8, 2026 at 06:26 UTC, according to Nexqual real-time market data.
VYGR last closed at USD 3.51; the session ranged USD 3.33–3.51 on volume of 406,747 shares. Market capitalization is —, with a 52-week range of USD 2.94–5.55 (NMS). Source: Nexqual, September 8, 2026 at 06:26 UTC.
Key Statistics (as of September 8, 2026 at 06:26 UTC)
| Price | USD 3.51 |
|---|---|
| Change | ▲ 3.85% (up) |
| Previous Close | USD 3.51 |
| Open | USD 3.51 |
| Day Range | USD 3.33 – 3.51 |
| 52-Week Range | USD 2.94 – 5.55 |
| Volume | 406,747 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VYGR)
Nexqual's technical model rates VYGR "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:26 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.95 (neutral) |
| vs SMA50 | Above (USD 3.32) |
| MACD | 0.06 (positive) |
From VYGR's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| SLDB | Solid Biosciences Inc. | USD 10.25 | ▼ 0.34% |
| QURE | uniQure N.V. | USD 44.5 | ▼ 3.74% |
| MGTX | MeiraGTx Holdings plc | USD 13.89 | ▼ 1.21% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:26 UTC. This page is informational and not investment advice.